(Q33956739)

30 July 2017

1 reference

title

A risk-benefit assessment of therapies for Lennox-Gastaut syndrome (English)

1 reference

30 July 2017

D Schmidt

1

1 reference

PubMed ID

10877040

30 July 2017

B Bourgeois

series ordinal

2

1 reference

30 July 2017

1 June 2000

1 reference

30 July 2017

1 reference

30 July 2017

22

1 reference

30 July 2017

6

1 reference

30 July 2017

467-477

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200022060-00005

30 July 2017

0 references

cites work

Felbamate in therapy-resistant epilepsy: an Italian experience

1 reference

12 December 2020

Callosotomy for intractable epilepsy: overall outcome

1 reference

12 December 2020

Quantification in patient urine samples of felbamate and three metabolites: acid carbamate and two mercapturic acids

1 reference

12 December 2020

Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group

1 reference

12 December 2020

Evolution of neuropsychological changes after partial callosotomy in intractable epilepsy.

1 reference

12 December 2020

Vagus nerve stimulation in 16 children with refractory epilepsy.

1 reference

12 December 2020

[Callosotomy in the treatment of drug-resistant epilepsy]

1 reference

12 December 2020

Lamotrigine in treatment of 120 children with epilepsy

1 reference

12 December 2020

Vigabatrin in childhood epilepsy.

1 reference

12 December 2020

Sodium valproate: monotherapy and polytherapy

1 reference

12 December 2020

Nitrazepam for refractory infantile spasms and the Lennox-Gastaut syndrome

1 reference

12 December 2020

Open study of clobazam in refractory epilepsy

1 reference

12 December 2020

Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

1 reference

12 December 2020

Double-blind placebo-controlled trial of flunarizine as add-on therapy in refractory childhood epilepsy.

1 reference

12 December 2020

Allopurinol add-on treatment in intractable seizures

1 reference

12 December 2020

The tolerability of lamotrigine in children

1 reference

12 December 2020

Long-term follow-up in patients with Lennox-Gastaut syndrome. Epileptological aspects, psychomotor development and social adaptation

1 reference

12 December 2020

Evaluation of case reports of aplastic anemia among patients treated with felbamate

1 reference

12 December 2020

Evaluation of refractory epilepsy treated with vagus nerve stimulation for up to 5 years

1 reference

12 December 2020

High-dose intravenous immunoglobulin treatment in cryptogenic West and Lennox-Gastaut syndrome; an add-on study

1 reference

12 December 2020

Lamotrigine and toxic epidermal necrolysis

1 reference

12 December 2020

Vagal nerve stimulation in epileptic encephalopathies.

1 reference

12 December 2020

Efficacy and safety of topiramate in refractory epilepsy: a long-term prospective trial.

1 reference

12 December 2020

Exacerbation of seizures in Lennox-Gastaut syndrome by gabapentin

1 reference

12 December 2020

A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group

1 reference

12 December 2020

Felbamate-associated fatal acute hepatic necrosis

1 reference

12 December 2020

Long-term prognosis of the Lennox-Gastaut syndrome.

1 reference

12 December 2020

The Efficacy of Lamotrigine in Children and Adolescents with Refractory Generalized Epilepsy: A Randomized, Double-Blind, Crossover Study

1 reference

12 December 2020

Bromide therapy for pediatric seizure disorder intractable to other antiepileptic drugs

1 reference

12 December 2020

Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy

1 reference

12 December 2020

Aplastic anemia in a patient receiving felbamate for complex partial seizures

1 reference

12 December 2020

Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).

1 reference

12 December 2020

Epileptic encephalopathies of early childhood

1 reference

12 December 2020

Intravenous immunoglobulin: a single-blind trial in children with Lennox-Gastaut syndrome

1 reference

12 December 2020

Corpus Callosotomy for Intractable Epilepsy: Seizure Outcome and Prognostic Factors

1 reference

12 December 2020

The Lennox-Gastaut syndrome

1 reference

12 December 2020

Effect of chronic electrical stimulation of the centromedian thalamic nuclei on various intractable seizure patterns: I. Clinical seizures and paroxysmal EEG activity

1 reference

12 December 2020

Results of anterior corpus callosum section in 24 patients with medically intractable seizures

1 reference

12 December 2020

Seizures decrease rapidly after fasting: preliminary studies of the ketogenic diet

1 reference

12 December 2020

Left vagus nerve stimulation in children with refractory epilepsy: an update

1 reference

12 December 2020

Valproic acid hepatic fatalities. III. U.S. experience since 1986.

1 reference

12 December 2020

Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month open-label study following a randomized clinical trial

1 reference

12 December 2020

Behavioral effects of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).

1 reference

12 December 2020

Lamotrigine: clinical experience in 93 patients with epilepsy.

1 reference

12 December 2020

10.2165/00002018-200022060-00005

Identifiers

DOI

1 reference

PubMed ID

10877040

Dimensions Publication ID

30 July 2017

0 references

1 reference

PubMed ID

10877040